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Abstract
Introduction: On March 6, 2020, the current ongoing pandemic of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), also known as COVID-19, reached the commonwealth of Kentucky. Within days, the first cases of infection and hospitalization were identified among healthcare
workers (HCW) in Kentucky, other states in the U.S., and
around the world. There is little information available regarding the impact of COVID-19 on the HCW population within this
area. The objective of this study was to describe the baseline
characteristics of hospitalized HCWs infected with COVID-19.
Methods: Data collection was performed as part of a retrospective study of patients hospitalized with COVID-19 in any
of the nine acute care hospitals in Louisville. COVID-19 infection was confirmed using reverse transcriptase-polymerase
chain reaction (RT-PCR). Descriptive statistics were performed on the clinical and epidemiological characteristics
of hospitalized patients with COVID-19 who had indicated
healthcare as their occupation.

Introduction
As of August 29, 2020, the World Health Organization
(WHO) has reported over 24.5 million cases of COVID19 with close to 850,000 deaths.[1] Many initial studies
have shown disproportionate rates of infection among
healthcare workers (HCWs).[2-9] One early study in
Wuhan, China described the clinical characteristics of
cases of COVID-19 among HCWs who provided care
for patients with known or suspected disease. They
found that among 138 hospitalized patients, 40 (29%)
were HCWs that were suspected of hospital-associated
transmission.[3]
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Results: Of the 700 adults hospitalized with COVID-19 from
March 7 through July 1, 2020, 23 were HCWs. The mean age
was 51 years, and 78% were female. The majority of hospitalized HCWs had comorbidities, including obesity (70%), hypertension (57%), hyperlipidemia (35%), and diabetes (26%).
Common symptoms reported were fever (70%), dyspnea
(78%), cough (78%), and fatigue (57%). Nine HCWs (39%)
were admitted to the intensive care unit (ICU), and six (26%)
developed acute respiratory distress syndrome (ARDS). Two
(9%) patients developed a new, serious arrhythmia, two sustained cardiac arrest (9%), and two (9%) died in the hospital.
Conclusions: Older adult HCWs with underlying health conditions, such as obesity and hypertension, were more likely
to be hospitalized and have severe in-hospital complications.
One HCW death due to COVID-19 was identified in this small
population. These findings can help to identify and strengthen
approaches to protect HCWs from SARS-CoV-2 infection and
from long-term effects of COVID-19.

A recent CDC study found that among COVID-19
cases reported between February 12 through April
9, 2020, 19% were identified as HCWs. The study
also found that 38% of the cases reported at least
one underlying health condition and the majority of
infected HCWs were not hospitalized (90%); however, 184 (2–5%) HCWs were admitted to the Intensive Care Unit (ICU) with 27 (0.3–0.6%) deaths. Common symptoms recognized among infected HCWs included fever, cough, shortness of breath, muscle aches
and headaches. Among the cases who reported exposure information, 55% stated their only contact was
in a healthcare setting within the 14 days before their
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illness onset.[10] As of August 29, CDC has reported
close to 700 deaths among HCWs with a caveat recognizing that these data likely fail to capture the true rate
of mortality due to COVID-19 in this group.[11]
Protecting HCWs from transmissible infection and recognizing when exposure may have occurred have long
been recognized as vital components in routine infection prevention and control practice in all settings
where healthcare is delivered. These factors stress the
importance of studying HCWs as a means of determining effective local policy and strategies that protect this vital infrastructure. The objective of this paper
is to describe the characteristics of hospitalized HCWs
diagnosed with COVID-19 illness admitted to one of
the nine adult hospitals in Louisville, Kentucky from
March through July 2020.

Methods
Study design
The Center of Excellence for Research in Infectious Diseases (CERID) at the University of Louisville maintains
an ongoing retrospective cohort study of hospitalized
patients infected with SARS CoV-2 to determine the
burden of COVID-19 in the Louisville, Kentucky area.
The main objective of this study was to explore the incidence, epidemiology, demographics, clinical characteristics and outcomes of hospitalized patients diagnosed
with COVID-19 admitted during the first four months
of the pandemic (March-July 2020) in Louisville.
Human Subjects Protection
The University of Louisville Institutional Review
Board approved the Burden of COVID-19 study (IRB
#20.0257), as well as the research offices at each participating hospital. The study was exempt from informed
consent. Study data were collected and managed using
HIPAA-compliant electronic capture data tools hosted
at the University of Louisville. REDCap (Research Electronic Data Capture) is a secure, web-based software
platform designed to support research studies.[12] All
information is considered protected health information
and standard data safety processes were followed.
Study Setting and Subjects
The Burden of COVID-19 study included nine acute
care hospitals in Louisville, Kentucky. The inclusion
criteria were to have either evidence of a positive Reverse Transcriptase-Polymerase Chain Reaction (RTPCR) on the first or the repeat test and/or presentation
of ground glass opacities on a chest computerized tomography (CT), including date of tests. Patients who
were not hospitalized/admitted to the any of the nine
hospitals were excluded (e.g., seen in an Emergency
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Department and discharged). A total of 700 adults
were hospitalized between March 7-July 1, 2020 and
captured for the Burden of COVID-19 study. A healthcare worker was defined in the Burden of COVID-19
study as having documentation of current occupation
as a healthcare worker in their medical record.
Data Collection
The RT-PCR testing was performed either by the University of Louisville Division of Infectious Diseases reference laboratory or at each respective hospital’s associated lab, with standard of care testing. Patients with
a confirmed or suspected positive COVID-19 diagnosis were ascertained either through daily screenings of
the hospital’s Electronic Medical Record (EMR) by the
CERID research team or from a daily report sent by
the hospital. Information collected included COVID-19
test results, demographic and hospitalization data, past
medical and social history, current medications, signs
and symptoms, physical examination, laboratory, radiologic and microbiologic findings, management and
therapies, in-hospital complications and clinical outcomes.
Statistical Analysis
Descriptive statistics were performed on relevant variables stratified by healthcare worker status, which was
categorized dichotomously (yes/no). Continuous data
are presented as mean±standard deviation (SD) if normally distributed or as median (interquartile range
[IQR]), if not normally distributed. Categorical data are
presented as frequency and percentage (%) as appropriate. All statistical analyses were performed using
R version 3.6.3 and R Studio version 1.2.5033 (Boston,
MA, USA).

Results
Among the 700 adults hospitalized with COVID-19, 23
(3%) met the healthcare worker definition and were
hospitalized from March 9 through June 20, 2020. All
23 hospitalized HCWs were confirmed COVID-19 positive by RT-PCR with 10 also positive for ground glass
opacities on CT exam. The mean age of hospitalized
HCWs was 51 years (SD=14.2) (Figure 1), mean body
mass index (BMI) was 35 kg/m2 (SD=8.8), 18 (78%)
were females and 13 (57%) were of Caucasian race
(Table 1). The majority of HCWs reported having at
least one symptom; 18 (78.0%) reported dyspnea, 18
(78%) reported cough, 16 (70%) reported a fever and
13 (57%) reported fatigue. Less common symptoms included myalgia, headache, cough with sputum, sore
throat, dizziness and diarrhea (Table 2). The median
duration from symptom onset to hospitalization was
4 days (IQR 3.0, 7.8). Physical examination findings
within the first 24 hours of admission were within nor-
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Figure 1. Distribution of ages among healthcare workers infected with COVID-19 hospitalized between March 9 and June 20, 2020 in Louisville,
Kentucky (n=23).

mal ranges except for minor deviations in heart rate
and oxygen saturation levels (Table 2). Laboratory results were also within normal ranges (Table 2).
All 23 hospitalized HCWs had at least one underlying health condition. Obesity (16 [70%]), hypertension
(13 [57%]), hyperlipidemia (8 [35%]), diabetes (6 [26%])
and asthma (5 [22%]) were the more common comorbidities (Figure 2). A total of nine HCWs were admitted to the ICU, with two of nine patients having two
ICU admits. Most of the hospitalized HCWs received
antibiotic therapy as a form of treatment (azithromycin;
15 [65%] and hydroxychloroquine; 8 [35%]). Of the 23
patients, 13 (57%) received high flow nasal cannula, 4
(17%) received vasopressors, 7 (30%) received inhaled
pulmonary vasodilators (IPV) and 4 (17%) patients
received noninvasive mechanical ventilation (NIMV)
(Table 3). In the ICU, 6 (26%) required invasive mechanical ventilation (IMV) during the hospitalization
(Table 3). The two most common in-hospital complications included acute respiratory distress syndrome
(ARDS) (6 [26%]) and septic shock (3 [13%]). Two (9%)
of the 9 ICU patients developed a new, serious arrhythmia, two sustained cardiac arrest (9%), and two (9%)
died in-hospital.
Mortality Profile
There were two documented deaths among the 23
hospitalized HCWs.
One patient was a 52-yearold, African American female, who tested positive
for COVID-19 by RT-PCR on the day of admission.
Her symptoms started 4 days before admission and
included fever, productive cough, dyspnea, nausea
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and fatigue. She had a past medical history of diabetes and hypertension and was on ace inhibitors, angiotensin receptor blockers, metformin and prednisone
at home. On admission, she was tachycardic, tachypneic, slightly hypoxic, documented as altered mental
status and had diffuse bilateral infiltrates on both chest
x-ray and CT. She was directly admitted to the ICU,
where she was treated with azithromycin for 2 days,
received high flow nasal cannula, CPAP, IPV and vasopressors. For one day, she was placed on NIMV but
later required IMV. Over the 7-day ICU course, the patient went into septic shock, developed ARDS and a
new, serious arrythmia and ultimately sustained cardiac arrest which led to her death.
The second patient was a 34-year-old, African American male HCW with an advanced directive. His symptoms started 2 days prior to hospitalization and included fatigue, cough and dyspnea. He was a current
smoker, had a past medical history of alcohol abuse
and asthma and was on a bronchodilator and antiepileptic medications. On admission, he was slight
tachypneic and hypoxic and had diffuse bilateral infiltrates on both chest x-ray and CT. Initial labs showed elevated white blood cell count, neutrophil count, bilirubin and liver function test. The patient was transferred to the ICU on the third day of admission, where
he tested positive for COVID-19 by RT-PCR and was
treated with azithromycin and cefepime. He also received plasma therapy, high flow nasal cannula, neuromuscular blockades, IPV, vasopressors and inotropes.
Over his 18-day ICU stay, the patient was also diagnosed with Methicillin-resistant Staphylococcus Aureus and was placed on systemic steroids. He shortly
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Table 1. Demographic characteristics of healthcare workers hospitalized with COVID-19.

Value (n=23)∗

Characteristic
Age (years), mean±SD
Age (years), n (%)
≤35
36-55
56-64
≥65
Body mass index (kg/m2 ), mean±SD
Body mass index (kg/m2 ), n (%)
Underweight (<18.50 kg/m2 )
Normal (18.50–24.99 kg/m2 )
Overweight (25.00–29.99 kg/m2 )
Obese (>30.00 kg/m2 )
Sex
Female
Male
Race
Black
White
Unknown
Ethnicity
Hispanic
Non-Hispanic
Unknown
Recent contact with another person with respiratory symptoms

51±14.2
5 (21.7)
9 (39.1)
6 (26.1)
3 (13.0)
35.0±8.8
0 (0.0)
3 (13.0)
4 (17.4)
16 (69.6)
18 (78.3)
5 (21.7)
8 (34.8)
13 (56.5)
2 (8.7)
0 (0.0)
21 (91.3)
2 (8.7)
12 (52.2)

Abbreviations: SD, standard deviation.
∗ Frequency and percentage except where otherwise specified. Percentages may
not total 100 due to rounding.

after developed ARDS requiring IMV, which he was on
for 16 days until his death.

Discussion
This study provides the first overview of the impact
of COVID-19 on healthcare workers in the Louisville,
Kentucky area. From March 6 through July 1, 2020,
23 HCWs were hospitalized with COVID-19 with two
documented deaths from COVID-19 pneumonia.
Overall, this hospitalized HCW population was older
with higher rates of comorbidities, unlike a recent CDC
report analyzing national data of HCWs infected with
COVID-19. The mean age in this study was 51 years
(SD 14.2) compared to a median of 42 years (IQR 32,
54) in a recent CDC report.[10] All hospitalized HCWs
with COVID-19 in this study had at least one underlying health condition compared to 38% and 35% in
other studies.[10, 13] One study showed significant increases in obesity prevalence among healthcare workers from 2004 through 2011.[14] However, the comorbidities among the HCWs in this study such as obesity, hypertension, diabetes and asthma were consistent
with state-level rates.[10, 13] Female HCWs (18 [78%])
were more likely to be hospitalized compared to males
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which was also consistent with several studies.[8-10,
13, 15] Common symptoms including fever, cough,
dyspnea, fatigue and myalgia were seen in U.S. analyses of HCWs with COVID-19.[10, 15, 16, 17] While
there was a lower percentage of hospitalized HCWs in
our study, there was a higher percentage of in-hospital
complications and death compared to other studies.[9,
10, 15] There was also a higher percentage of hospitalized HCWs admitted to the ICU, as well as HCWs
with ARDS and septic shock.[9, 10, 15] Treatments such
as hydroxychloroquine and azithromycin given to the
HCWs in this study reflected the state of knowledge at
the time and are no longer standard of care. One randomized controlled trial showed that using hydroxychloroquine with or without azithromycin on patients
hospitalized with COVID-19 did not improve their 15day clinical status compared to standard care.[18] The
standard care included the use of antibiotics, anti-viral
agents, glucocorticoids and others, at the discretion of
the physician.[18]
Kentucky’s first COVID-19 case was confirmed on
March 6, 2020 and a state of emergency was declared.
Local testing through the University of Louisville was
readily available and allowed for rapid testing. The
baseline characteristics of HCWs hospitalized with
COVID-19 can help to inform healthcare policies re-
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Table 2. Signs, symptoms, and physical and laboratory findings of healthcare workers hospitalized with COVID-19.

Characteristic

Value (n=23)

symptoms∗

Signs and
Fever
Dyspnea
Cough
Sputum
Myalgia
Fatigue
Headache
Time from illness onset to admission (days), median [IQR], n=22

16 (69.6)
18 (78.3)
18 (78.3)
4 (17.4)
10 (43.5)
13 (56.5)
2 (8.7)
4.0 [3.0, 7.8]

Physical examination†‡
Heart rate (beats/minute), mean±SD
Respiratory rate (breaths/minute)
Systolic blood pressure (mmHg), mean±SD
Diastolic blood pressure (mmHg), mean±SD
Temperature (°C)
O2 saturation, %, n=22
FiO2, n=20
Altered mental status, n (%)

98.4±18.7
20.0 [18.0, 23.5]
123.0±20.3
65.7±10.8
38.1 [37.1, 39.3]
94.5 [92.3, 97.0]
21.0 [21.0, 24.5]
1 (4.4)

Laboratory findings†
Hemoglobin (mg/dL), mean±SD
White Blood Count, (×1,000 per µL)
Platelet count (×1,000 per µL), mean±SD
Neutrophil count (×1,000 per µL)
Lymphocyte count (×1,000 per µL)
C-reactive protein, (mg/L)), n=13
Serum bicarbonate (mEq/L), n=22
Procalcitonin (<0.05 µg/L), n=16

13.1±1.8
5.8 [4.8, 7.6]
195.1±61.3
3.8 [3.3, 6.3]
1.1 [0.9, 1.6]
8.8 [2.7, 27.0]
24.0 [22.0, 27.4]
0.05 [0.05, 0.09]

Abbreviations: IQR, interquartile range; SD, standard deviation.
∗ Frequency and percentage except where otherwise specified. Percentages may not
total 100 due to rounding.
† Median [IQR] except where otherwise specified.
‡ Physical exam within the first 24 hours of hospitalization.

garding infection control including personal protective
equipment (PPE). One recent rapid review of eleven
articles found that work overload, underlying comorbidities, lack of PPE, exposure to infected patients and
poor infection control were the main risk factors of
COVID-19 infection among HCWs.[19] These risk factors along with the atypical clinical manifestations of
COVID-19 and asymptomatic but infectious cases may
not have been recognized in the early phase of the pandemic leading to higher rates of severe COVID-19 cases
among HCWs.
There are a few limitations to acknowledge. The results
of this retrospective study may not be generalizable to
all HCWs or the public as they may be significantly different from HCWs hospitalized with COVID-19. Due
to the nature of this retrospective, observational study,
we were not able to collect more detailed information
on the classification of healthcare workers and exposures or causes of COVID-19 infection. The healthcare
worker definition was self-reported and may not have
included all personnel who work in a healthcare setting that have direct or indirect exposure to COVIDULJRI | https://ir.library.louisville.edu/jri/vol4/iss1/75

19 patients limiting the sample size to 21. The small
sample size of HCWs hospitalized with COVID-19 may
reflect the availability of PPE and effective infection
control processes or it may reflect more asymptomatic
cases among HCWs. Future research should consider
using prospective studies to follow healthy, uninfected
HCWs to COVID-19 infection, so as to fully understand
transmission modes, risk factors and biological mechanisms.
The current, ongoing COVID-19 pandemic remains
a growing public health problem, putting frontline
HCWs at the highest risk of infection. This retrospective analysis describes the characteristics of HCWs hospitalized with COVID-19 from March 9 through June
20, 2020 in Louisville, Kentucky. These findings suggest that older, obese HCWs with underlying comorbidities may be more likely to be hospitalized with severe COVID-19 infection. Further, the long-term impacts of COVID-19 and their relevance to the ability
and willingness of the HCW to return to work should
be part of ongoing research.
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Figure 2. Comorbidities of healthcare workers hospitalized with COVID-19 (n=23). Abbreviations: CAD, coronary artery disease.

Table 3. Treatments and complications of healthcare workers hospitalized with COVID-19.

Characteristic

∗

Value (n=23)∗

Treatment in hospital
Hydroxychloroquine
Azithromycin
Remdesivir
High flow nasal cannula
Continuous positive airway pressure (CPAP)
Non-invasive mechanical ventilation
Invasive mechanical ventilation
Proning position
Plasma therapy
Neuromuscular blockade/artificial paralysis
Inhaled pulmonary vasodilators
Vasopressors
Inotropes

8 (34.8)
15 (65.2)
2 (8.7)
13 (56.5)
2 (8.7)
4 (17.4)
6 (26.1)
5 (21.7)
3 (13.0)
5 (21.7)
7 (30.4)
4 (17.4)
1 (4.4)

In-hospital complications
Acute respiratory disease syndrome
Septic shock
Development of heart failure
Sustained cardiac arrest
Development of acute myocardial infarction
Pulmonary edema
Pulmonary embolism
Development of new, serious arrhythmia
Cerebrovascular accident
Mortality

6 (26.1)
3 (13.0)
0 (0.0)
2 (8.7)
0 (0.0)
0 (0.0)
0 (0.0)
2 (8.7)
0 (0.0)
2 (8.7)

n (%).
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